Belviq Cancer Problems Cause Concerns For Users of Weight Loss Drug
Belviq cancer concerns arose before the weight loss drug was even approved, but it never carried a cancer warning label.…
«
»
Belviq cancer concerns arose before the weight loss drug was even approved, but it never carried a cancer warning label.…
A federal appeals court has rejected efforts by Pfizer to overturn a recent lower court decision, which allows individuals diagnosed with persistent pulmonary hypertension (PPH) that developed years after their last use of fen phen to move forward with product liability lawsuits against the makers of the diet drug.…
Nearly 15 years after a federal multidistrict litigation (MDL) was established for all fen-phen lawsuits filed over side effects of the recalled diet drug, new cases continue to be transferred into the consolidated proceedings.…
The new weight loss drug Qsymia was introduced to the market this week, despite the risk of birth defects from topiramate, one of the active ingredients, and other safety concerns that caused the FDA to delay approval of the prescription medication. …
A federal judge has rejected an attempt by Pfizer to cut-off new lawsuits over fen-phen, which continue to be brought by individuals who indicate that they developed persistent pulmonary hypertension (PPH) from side effects of the weight-loss drug years after it was recalled from the market. …